Literature DB >> 25120789

Decreased LINE-1 methylation levels in aldosterone-producing adenoma.

Chen Chen1, Xiaoyu Zhou2, Jing Jing1, Jing Cheng1, Yu Luo1, Jiachao Chen1, Xi Xu1, Fei Leng1, Xiaomu Li1, Zhiqiang Lu1.   

Abstract

PURPOSE: Abnormal global DNA methylation levels are associated with many diseases. In this study, we examined long interspersed nuclear elements-1 (LINE-1) methylation as a biomarker for abnormal global DNA methylation and aldosterone-producing adenoma (APA).
METHODS: Tissues from 25 APA and 6 normal adrenal glands (NAs) were analyzed for LINE-1 methylation by real-time methylation-specific polymerase chain reaction. The estimated LINE-1 methylation level was then tested for correlation with the clinicopathologic parameters of APA patients.
RESULTS: The methylation index (MI) level for LINE-1 was 0.91 in NA samples and 0.77 in APA samples (P < 0.001). For the APA samples, there were no statistical correlations between the MI level and various clinicopathologic parameters such as gender (P = 0.07).
CONCLUSION: LINE-1 methylation is significantly lower in APA samples than in NA samples. LINE-1 methylation is not correlated with the clinical characteristics of APA.

Entities:  

Keywords:  Long interspersed nuclear elements-1; aldosterone-producing adenoma; global DNA methylation

Mesh:

Year:  2014        PMID: 25120789      PMCID: PMC4129024     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  29 in total

1.  Initial sequencing and analysis of the human genome.

Authors:  E S Lander; L M Linton; B Birren; C Nusbaum; M C Zody; J Baldwin; K Devon; K Dewar; M Doyle; W FitzHugh; R Funke; D Gage; K Harris; A Heaford; J Howland; L Kann; J Lehoczky; R LeVine; P McEwan; K McKernan; J Meldrim; J P Mesirov; C Miranda; W Morris; J Naylor; C Raymond; M Rosetti; R Santos; A Sheridan; C Sougnez; Y Stange-Thomann; N Stojanovic; A Subramanian; D Wyman; J Rogers; J Sulston; R Ainscough; S Beck; D Bentley; J Burton; C Clee; N Carter; A Coulson; R Deadman; P Deloukas; A Dunham; I Dunham; R Durbin; L French; D Grafham; S Gregory; T Hubbard; S Humphray; A Hunt; M Jones; C Lloyd; A McMurray; L Matthews; S Mercer; S Milne; J C Mullikin; A Mungall; R Plumb; M Ross; R Shownkeen; S Sims; R H Waterston; R K Wilson; L W Hillier; J D McPherson; M A Marra; E R Mardis; L A Fulton; A T Chinwalla; K H Pepin; W R Gish; S L Chissoe; M C Wendl; K D Delehaunty; T L Miner; A Delehaunty; J B Kramer; L L Cook; R S Fulton; D L Johnson; P J Minx; S W Clifton; T Hawkins; E Branscomb; P Predki; P Richardson; S Wenning; T Slezak; N Doggett; J F Cheng; A Olsen; S Lucas; C Elkin; E Uberbacher; M Frazier; R A Gibbs; D M Muzny; S E Scherer; J B Bouck; E J Sodergren; K C Worley; C M Rives; J H Gorrell; M L Metzker; S L Naylor; R S Kucherlapati; D L Nelson; G M Weinstock; Y Sakaki; A Fujiyama; M Hattori; T Yada; A Toyoda; T Itoh; C Kawagoe; H Watanabe; Y Totoki; T Taylor; J Weissenbach; R Heilig; W Saurin; F Artiguenave; P Brottier; T Bruls; E Pelletier; C Robert; P Wincker; D R Smith; L Doucette-Stamm; M Rubenfield; K Weinstock; H M Lee; J Dubois; A Rosenthal; M Platzer; G Nyakatura; S Taudien; A Rump; H Yang; J Yu; J Wang; G Huang; J Gu; L Hood; L Rowen; A Madan; S Qin; R W Davis; N A Federspiel; A P Abola; M J Proctor; R M Myers; J Schmutz; M Dickson; J Grimwood; D R Cox; M V Olson; R Kaul; C Raymond; N Shimizu; K Kawasaki; S Minoshima; G A Evans; M Athanasiou; R Schultz; B A Roe; F Chen; H Pan; J Ramser; H Lehrach; R Reinhardt; W R McCombie; M de la Bastide; N Dedhia; H Blöcker; K Hornischer; G Nordsiek; R Agarwala; L Aravind; J A Bailey; A Bateman; S Batzoglou; E Birney; P Bork; D G Brown; C B Burge; L Cerutti; H C Chen; D Church; M Clamp; R R Copley; T Doerks; S R Eddy; E E Eichler; T S Furey; J Galagan; J G Gilbert; C Harmon; Y Hayashizaki; D Haussler; H Hermjakob; K Hokamp; W Jang; L S Johnson; T A Jones; S Kasif; A Kaspryzk; S Kennedy; W J Kent; P Kitts; E V Koonin; I Korf; D Kulp; D Lancet; T M Lowe; A McLysaght; T Mikkelsen; J V Moran; N Mulder; V J Pollara; C P Ponting; G Schuler; J Schultz; G Slater; A F Smit; E Stupka; J Szustakowki; D Thierry-Mieg; J Thierry-Mieg; L Wagner; J Wallis; R Wheeler; A Williams; Y I Wolf; K H Wolfe; S P Yang; R F Yeh; F Collins; M S Guyer; J Peterson; A Felsenfeld; K A Wetterstrand; A Patrinos; M J Morgan; P de Jong; J J Catanese; K Osoegawa; H Shizuya; S Choi; Y J Chen; J Szustakowki
Journal:  Nature       Date:  2001-02-15       Impact factor: 49.962

2.  Induction of tumors in mice by genomic hypomethylation.

Authors:  François Gaudet; J Graeme Hodgson; Amir Eden; Laurie Jackson-Grusby; Jessica Dausman; Joe W Gray; Heinrich Leonhardt; Rudolf Jaenisch
Journal:  Science       Date:  2003-04-18       Impact factor: 47.728

3.  Global DNA methylation changes in blood of patients with essential hypertension.

Authors:  Iwona Smolarek; Eliza Wyszko; Anna M Barciszewska; Stanislaw Nowak; Iwona Gawronska; Anna Jablecka; Miroslawa Z Barciszewska
Journal:  Med Sci Monit       Date:  2010-03

4.  Elevated expression of the stem cell marker CD133 associated with Line-1 demethylation in hepatocellular carcinoma.

Authors:  Changsong Zhang; Yun Xu; Jun Zhao; Lieying Fan; Guocheng Jiang; Rong Li; Yang Ling; Mengchao Wu; Lixin Wei
Journal:  Ann Surg Oncol       Date:  2011-02-18       Impact factor: 5.344

Review 5.  Hypomethylation: one side of a larger picture.

Authors:  Barbara K Dunn
Journal:  Ann N Y Acad Sci       Date:  2003-03       Impact factor: 5.691

Review 6.  The impact of retrotransposons on human genome evolution.

Authors:  Richard Cordaux; Mark A Batzer
Journal:  Nat Rev Genet       Date:  2009-10       Impact factor: 53.242

7.  Methylation levels of LINE-1 repeats and CpG island loci are inversely related in normal colonic mucosa.

Authors:  Barry Iacopetta; Fabienne Grieu; Michael Phillips; Andrew Ruszkiewicz; James Moore; Toshinari Minamoto; Kazuyuki Kawakami
Journal:  Cancer Sci       Date:  2007-07-19       Impact factor: 6.716

8.  Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline.

Authors:  John W Funder; Robert M Carey; Carlos Fardella; Celso E Gomez-Sanchez; Franco Mantero; Michael Stowasser; William F Young; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2008-06-13       Impact factor: 5.958

Review 9.  DNA methylation in cancer: too much, but also too little.

Authors:  Melanie Ehrlich
Journal:  Oncogene       Date:  2002-08-12       Impact factor: 9.867

10.  Association between global DNA hypomethylation in leukocytes and risk of breast cancer.

Authors:  Ji-Yeob Choi; Smitha R James; Petra A Link; Susan E McCann; Chi-Chen Hong; Warren Davis; Mary K Nesline; Christine B Ambrosone; Adam R Karpf
Journal:  Carcinogenesis       Date:  2009-07-07       Impact factor: 4.944

View more
  2 in total

1.  Aldosterone-to-renin ratio acts as the predictor distinguishing the primary aldosteronism from chronic kidney disease.

Authors:  Wei-Guo Chen; Ting-Ting Zhou; Peng Zhou; Xiao-Wei Li; Zhun Wu; Kai-Yan Zhang; Jin-Chun Xing
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

2.  Hypomethylation of CYP11B2 in Aldosterone-Producing Adenoma.

Authors:  Yoko Yoshii; Kenji Oki; Celso E Gomez-Sanchez; Haruya Ohno; Kiyotaka Itcho; Kazuhiro Kobuke; Masayasu Yoneda
Journal:  Hypertension       Date:  2016-10-17       Impact factor: 10.190

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.